FILED PURSUANT TO RULE 424(b)(3)
                                             REGISTRATION STATEMENT NO. 333-3716

                      SUPPLEMENT NO. 1 DATED MAY 17, 1996
                       TO PROSPECTUS DATED APRIL 29, 1996
                        RELATING TO 1,814,632 SHARES OF
                         RENAL TREATMENT CENTERS, INC.
                          COMMON STOCK, $.01 PAR VALUE


     All capitalized terms used but not defined herein shall have the meanings
prescribed in the Prospectus dated April 29, 1996 forming a part of Form S-3
Registration Statement No. 333-3716.

     Dudley S.J. Seto, M.D., a Selling Stockholder, has transferred 523,732 of
the 1,047,464 shares of Common Stock beneficially owned by him and covered by
the Prospectus  to a revocable trust of which he is sole beneficiary and trustee
and transferred the remaining 523,732 shares of Common Stock beneficially owned
by him and covered by the Prospectus to a revocable trust of which his spouse is
sole beneficiary and trustee.  Dr. Seto and his spouse share voting and
investment power with respect to all 1,047,464 shares of Common Stock, and each
may be considered the beneficial owner of all 1,047,464 shares.

     B.J. Matter, M.D., a Selling Stockholder, has transferred all 286,598
shares of Common Stock beneficially owned by him and covered by the Prospectus
to a family limited partnership, of which Dr. Matter is the sole general
partner.  Therefore, Dr. Matter has retained sole voting and investment power
with respect to all 286,598 shares.

     Dennis R. Mask, M.D., a Selling Stockholder, has transferred all 286,598
shares of Common Stock beneficially owned by him and covered by the Prospectus
to a family limited partnership, of which Dr. Mask is the sole general partner.
Therefore, Dr. Mask has retained sole voting and investment power with respect
to all 286,598 shares.